Auch auf CNBC heute, bitte mal genau nachlesen:
Swiss drugmaker Lonza has partnered with Moderna and says it aims to produce 400 million doses of the vaccine annually. The U.S. firm is aiming for 500 million to 1 billion doses in total for 2021. Anyone receiving the vaccine will require two doses, as with Pfizers shot, showing how long it could take, with the current manufacturing capacity, to vaccinate internationally.
Lonza will produce ingredients within Modernas vaccine, formally called mRNA-1273, in facilities in the U.S. and Switzerland, where it is headquartered. Company Chairman Albert Baehny told CNBC about the big challenges facing drugmakers like his when it comes to scaling up production.
We can only produce more than 500 million doses a year if we install additional manufacturing lines, so it is clear that we need additional investments in installation if we want to produce more than 500 million (per year) in the future, he told CNBCs Squawk Box Europe on Wednesday.
Baehny identified more challenges to vaccine production that the company has had to confront since embarking on its partnership with Moderna.
There are a few issues, the first is speed. We only started 10, 11 months ago and now we are producing the first commercial batches of the drug substance in North America, and we are planning the first batch of commercial volume in one or two weeks in Switzerland, so the speed has been a challenge.
The second challenge is to find the people. For each manufacturing line you need 60-70 educated persons. Weve installed four manufacturing lines so you have to identify and train these people, he said.
Then linked to the speed (issue), you have to have access to the equipment, install the equipment, and then test your manufacturing facility, so (these are) big challenges, resolved, or almost resolved, in less than one year.
Quelle: CNBC
Das heisst doch moderna kommt einfach nicht mit der Lieferung von Milliarden von Impfstoff Dosen hinterher!
Kein Equipment und keine fähigen Leute um einfach mal weitere Produktionslinien bei Lonza aufzubauen, really?
Wer hat nochmal grosse Produktionslinien in der EU und in den USA?
Wer hat gerade nochmal eine ganze Bio-Facility in Deutschland mir 300 höchst fähigen Mitarbeitern aufgekauft?
Wer hat Kooperationspartner die auch den riesigen Chinesischen Markt bedienen werden?
Ha, wenn sich der Staub um die Effekthascherei bei moderna gelegt hat, und wenn Fakten im Vordergrund stehen, dann wird BNTX davon ziehen ;-)
DBBH
Zurück
Weiter
